At treatlink, we strive to make a major contribution to improving therapies and survival rates for patients with Glioblastoma. We are convinced that even a disease as aggressive as glioblastoma can, in the long-run, become curable through the combination of modern therapeutic approaches and personalized alignment with the patient-specific biosignature.
